WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010033495) FUNCTIONALLY SELECTIVE AZANITRILE ALPHA2C ADRENORECEPTOR AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/033495    International Application No.:    PCT/US2009/056967
Publication Date: 25.03.2010 International Filing Date: 15.09.2009
IPC:
C07D 471/04 (2006.01), C07D 491/052 (2006.01), A61K 31/436 (2006.01), A61K 31/437 (2006.01), A61P 29/00 (2006.01), A61P 11/00 (2006.01)
Applicants: SCHERING CORPORATION [US/US]; 2000 Galloping Hill Road Kenilworth, New Jersey 07033-0530 (US) (For All Designated States Except US).
BOYCE, Christopher W [US/US]; (US) (For US Only).
CHAO, Jianhua [CN/US]; (US) (For US Only).
MCCORMICK, Kevin D. [US/US]; (US) (For US Only)
Inventors: BOYCE, Christopher W; (US).
CHAO, Jianhua; (US).
MCCORMICK, Kevin D.; (US)
Agent: RUSSELL, Mark W.; Schering-plough Corporation Patent Department K-6-1 1990 2000 Galloping Hill Road Kenilworth, New Jersey 07033 (US)
Priority Data:
61/097,412 16.09.2008 US
Title (EN) FUNCTIONALLY SELECTIVE AZANITRILE ALPHA2C ADRENORECEPTOR AGONISTS
(FR) AGONISTES DE L'ADRÉNORÉCEPTEUR Α2C À BASE D'AZANITRILE FONCTIONNELLEMENT SÉLECTIFS
Abstract: front page image
(EN)In its many embodiments, the present invention provides a novel class of azanitrile compounds as inhibitors of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.
(FR)La présente invention concerne, parmi ses nombreux modes de réalisation, une classe inédite de composés de type azanitrile constituant des inhibiteurs des agonistes du récepteur α2C adrénergique, des procédés de préparation desdits composés, des compositions pharmaceutiques contenant un ou plusieurs desdits composés, des procédés de préparation de formes pharmaceutiques contenant un ou plusieurs desdits composés et des procédés de traitement, de prévention, d'inhibition ou d'amélioration d'une ou plusieurs affections associées aux récepteurs α2C adrénergiques au moyen desdits composés ou desdites compositions pharmaceutiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)